Colorectal cancer molecular profiling: Opportunities for early detection

Area of Science:

• Oncology
• Biomarkers
• Cancer Diagnostics

Background:

• Colorectal cancer (CRC) presents a significant global health challenge with rising incidence rates.
• Current CRC screening methods often suffer from poor adherence or insufficient sensitivity for early detection.
• There is a critical need for innovative, cost-effective, and minimally invasive diagnostic tools.

Purpose of the Study:

• To review the current landscape of colorectal cancer (CRC) statistics, risk factors, and genetic characteristics.
• To emphasize the importance of non-tumor-derived information in premalignant states for early CRC detection.
• To evaluate existing UK and USA screening programs and explore emerging diagnostic technologies.

Main Methods:

• Literature review and synthesis of current research on CRC.
• Analysis of the limitations of existing screening protocols.
• Discussion of prospective diagnostic approaches including genomics, proteomics, and spectroscopy.

Main Results:

• Current screening tests have limitations in adherence and sensitivity for early-stage colorectal cancer (CRC).
• Non-tumor-derived biomarkers, reflecting immune and metabolic changes, hold promise for early detection.
• Emerging technologies like genomics, proteomics, and spectroscopy offer potential advancements.

Conclusions:

• Improved diagnostic strategies are essential to lower advanced-stage CRC incidence.
• Focusing on non-tumor-derived information in premalignant stages is key for earlier CRC diagnosis.
• Minimally invasive and cost-effective tests are vital for enhancing CRC screening effectiveness.